Colorectal cancer early screening primer group based on four genes and kit

A colorectal cancer, primer set technology, applied in the biological field, can solve the problems of high false negatives in detection, affecting the judgment of results, etc., to improve the accuracy and comprehensiveness, reduce the proportion of false negatives, and reduce the proportion of false negatives. Effect

Active Publication Date: 2018-05-11
达瑞医学检验(广州)有限公司
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, most of these detection kits only detect one or two hotspot mutation gene sites, and the detection sequence is limited to the local sequence of the gene. At present, it has been found that many hotspot...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Colorectal cancer early screening primer group based on four genes and kit
  • Colorectal cancer early screening primer group based on four genes and kit
  • Colorectal cancer early screening primer group based on four genes and kit

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] Example 1 Detection of primer sequences for exon mutations in four genes of APC, CTNNB1, B-raf and K-ras

[0037] (1) A group of primers for detecting mutation sites of all exons of APC, CTNNB1, B-raf, and K-ras genes

[0038]A group of primers for the whole exon mutation sites of APC, CTNNB1, B-raf, and K-ras genes are as follows:

[0039] The sequence shown in SEQ ID NO: 001-058 is the forward and reverse primers for amplifying and covering the whole exon mutation site of APC gene;

[0040] The sequence shown in SEQ ID NO: 117-136 is the forward and reverse primers for amplifying the mutation site covering the whole exon of CTNNB1 gene;

[0041] The sequence shown in SEQ ID NO: 157-184 is the forward and reverse primers for amplifying and covering the whole exon mutation site of B-raf gene;

[0042] The sequences shown in SEQ ID NO: 211-216 are forward and reverse primers for amplifying and covering the whole exon mutation site of K-ras gene.

[0043] In the detect...

Embodiment 2

[0051] Example 2 The method for detecting hotspot mutations in the whole exons of four genes APC, CTNNB1, B-raf and K-ras

[0052] (1) Genomic DNA extraction from feces

[0053] 1) Take 200mg of feces in a test tube (if the stool sample is liquid, take 200μL in the test tube), add 2mL of PBS to shake and mix well, centrifuge at 3000g for 5 minutes, and collect the supernatant; take 1mL of the collected supernatant in 1.5mL In a centrifuge tube, centrifuge at 12,000 rpm for 5 minutes, discard the supernatant, and resuspend the pellet with 1 mL of PBS. After shaking and mixing, centrifuge at 12,000 rpm for 5 minutes to collect the pellet.

[0054] 2) Add 200 μL of 1% SDS, suspend the precipitate, and place it at 37° C. for 30 minutes.

[0055] 3) Add 200 μL of proteinase K and 20 μL of digestion solution, shake and mix well, and bathe in water at 56°C for 10 minutes.

[0056] 4) Add 600 μL of 15% ethanol, gently invert and mix well. If there is a translucent suspension, it wil...

Embodiment 3

[0082] Example 3 Using the primers and methods provided by the present invention to detect clinical samples

[0083] Six clinical stool samples were taken from the hospital, all of which were not determined to be colorectal cancer patients, and whether there were four gene exon mutations of APC, CTNNB1, B-raf and K-ras in the 6 samples. Genomic DNA was extracted according to the method described in Example 2, and reagents were prepared and detected. After each sample was sequenced, the 55 known hotspot mutations were compared with the wild-type genome sequence, and finally based on the sequencing results, it was preliminarily judged whether the patient had new mutations in the four genes and whether he was a colorectal cancer patient.

[0084] The test results are shown in the table below:

[0085] Sample serial number

Sequencing results

colorectal cancer patients

1

no mutation

no

2

no mutation

no

3

K-ras G12D

yes

...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a colorectal cancer early screening primer group based on four genes. The primer group specifically comprises the following primers including 58 pairs of forward and reverse primer groups, 20 pairs of forward and reverse primer groups, 27 pairs of forward and reverse primer groups and 7 pairs of pairs of forward and reverse primer groups, wherein the 58 pairs of forward andreverse primer groups are used for amplifying, covering and detecting whole exon sequence mutation sites of the APC gene, and the nucleotide sequences of the primer groups are as shown in SEQ ID NO:001-116; the 20 pairs of forward and reverse primer groups are used for amplifying, covering and detecting whole exon sequence mutation sites of the CTNNB1 gene, and the nucleotide sequences of the primer groups are as shown in SEQ ID NO:117-156; the 27 pairs of forward and reverse primer groups are used for amplifying, covering and detecting whole exon sequence mutation sites of the B-raf gene, andthe nucleotide sequences of the primer groups are as shown in SEQ ID NO:157-210; the 7 pairs of forward and reverse primer groups are used for amplifying, covering and detecting whole exon sequence mutation sites of the K-ras gene, the nucleotide sequences of the primer groups are as shown in SEQ ID NO:211-224. Exons of the four genes can be completely amplified through the method, all the mutation sites to be detected can be covered, and the accuracy of screening detection is ensured.

Description

technical field [0001] The invention relates to the field of biotechnology, in particular to a primer set and kit for early screening of colorectal cancer based on four genes. Background technique [0002] Colorectal cancer (CRC) is a malignant tumor originating from the colorectal mucosal epithelium, and is one of the most common malignant tumors in clinic. There are more than 250,000 new cases of colorectal cancer in my country every year, and about 140,000 deaths, accounting for 20% of the world's colorectal cancer cases in the same period. However, at present, the early diagnosis rate of colorectal cancer in my country is very low. Compared with European and American countries, my country still needs to vigorously popularize early screening of colorectal cancer, improve the early diagnosis rate of colorectal cancer in my country, and reduce colorectal cancer-related mortality. [0003] Sporadic colonic adenomas are recognized as precancerous lesions, and the risk of mal...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12Q1/6886C12N15/11
CPCC12Q1/6886C12Q2600/156
Inventor 李明杨俊陆颖锶韩丽娜黄曦周进生何金津丘远辉
Owner 达瑞医学检验(广州)有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products